Exploring the Association of Imaging and Tumor Microenvironment in Urologic Cancer Using Radiogenomic Approach(Radiogenomics-Urinary)
NCT06537037 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2024-08-05
Summary
This is the prospective, observational cohort study (Radiogenomics-Urinary), which aims to explore the relationship between the imaging information of urologic cancer patients, tumor microenvironment and the prognosis of urologic cancer patients.
Conditions
- Urologic Cancer
Sponsors & Collaborators
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-31
- Primary Completion
- 2027-08-31
- Completion
- 2027-08-31
Countries
- China
Study Locations
More Related Trials
-
Exploring the Correlation Between MRI Image Characteristics and Diagnosis, Pathology and Prognosis in Patients With Prostate Lesions
NCT06946771 ·Status: RECRUITING
-
Investigation of Tumor Microenvironment After CRPC Along With Before and After Neoadjuvant Therapy for Prostate Cancer
NCT05522907 ·Status: NOT_YET_RECRUITING
-
A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer
NCT06696326 ·Status: RECRUITING ·Phase: NA
-
Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate Biopsy
NCT05761912 ·Status: ACTIVE_NOT_RECRUITING
-
CEUS Targeted Biopsies Compared to mpMRI Targeted and Systematic Biopsies for the Detection of Prostate Cancer
NCT02831920 ·Status: UNKNOWN ·Phase: NA
-
Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image Features
NCT06604377 ·Status: COMPLETED
-
Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT06462508 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate Cancer
NCT06737588 ·Status: RECRUITING
-
Threedimensional Multiparametric Ultrasound for Prostate Cancer Detection
NCT04605276 ·Status: COMPLETED
-
Research on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and Restaging of Prostate Cancer
NCT07056790 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT05955677 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Sequential bpMRI for Suspicious Prostate Lesions
NCT07332832 ·Status: NOT_YET_RECRUITING
-
Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique
NCT02940977 ·Status: UNKNOWN
-
a Study of Combined mpMRI and PSMA PET/CT for Highly Suspicious Patients Performing Radical Prostatectomy Without Biopsy
NCT05670691 ·Status: UNKNOWN
-
Bp-MRI Based Multi-planar VI-RADS
NCT06607250 ·Status: COMPLETED
-
68Ga-labeled NY108 PET Imaging in Patients
NCT05623878 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Imaging for Significant Prostate Cancer Risk Evaluation
NCT01492270 ·Status: UNKNOWN ·Phase: NA
-
99mTc-P137 SPECT/CT in Prostate Cancer
NCT05672485 ·Status: RECRUITING ·Phase: NA
-
Multi-Modal Image Fusion for Precision Prostate Biopsy Navigation
NCT06441292 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
NCT06056830 ·Status: RECRUITING ·Phase: PHASE3
-
68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients
NCT03164837 ·Status: UNKNOWN ·Phase: PHASE1
-
Prediction of the Risk of Biochemical Relapse After Radical Prostatectomy for Prostate Cancer Using Radomics on Pre-therapeutic MRI
NCT04063800 ·Status: COMPLETED
-
68Ga-NOTA-BBN-RGD PET/CT in Prostate Cancer Patients
NCT02747290 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT06756334 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate Cancer
NCT03451812 ·Status: UNKNOWN